Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-04T17:56:17.436Z Has data issue: false hasContentIssue false

Intravenous tPA for acute stroke

Published online by Cambridge University Press:  21 May 2015

Gord Gubitz
Affiliation:
Neurology, [email protected]
Steve Phillips
Affiliation:
Neurology, [email protected], Queen Elizabeth II Health Sciences Centre, Halifax, NS

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters • Courrier
Copyright
Copyright © Canadian Association of Emergency Physicians 2001

References

1.Rhine, D.Intravenous tPA for acute stroke: Any and all hospitals? Any and all docs? CJEM 2000; 2(3):18991.CrossRefGoogle ScholarPubMed
2.Katzan, IL, Furlan, AJ, Lloyd, LE, Frank, JI, Harper, DL, Hinchley, JA, et al. Use of tissue-type plasminogen activator for acute stroke: the Cleveland area experience. JAMA 2000;283(9):11518.CrossRefGoogle ScholarPubMed
3.Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333(24):15817.Google Scholar
4.Wardlaw, JM, del Zoppo, G, Yamaguchi, T. Thrombolytic therapy in acute ischaemic stroke. Part 1: Thrombolysis versus control. Oxford: Update Software. The Coch-rane Library 2000: issue 2.Google Scholar
5.Gubitz, G, Sandercock, P, Counsell, C, Signorini, D. Anticoagulants for acute ischaemic stroke. Oxford: Update Software. The Cochrane Library 2000: issue 2.Google Scholar